Literature DB >> 2950087

Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vector.

A Majumdar, S Rudikoff, S Adhya.   

Abstract

The galR gene, which encodes the Gal repressor protein in Escherichia coli, has been fused to the strong pL promoter of bacteriophage lambda in plasmid pKC31. The pL promoter is kept repressed by a thermolabilie lambda repressor, CIts857, to prevent cell killing. Heat induction of the pL-galR fusion plasmid synthesizes large amounts of active Gal repressor. The protein has been purified to homogeneity in three steps. The purification is greatly aided by the reversible insolubility of active repressor in crude extract at salt concentrations of less than 200 mM. The amino-terminal amino acid sequence determined by automated Edman degradation is: N-Ala-Thr-Ile-Lys-Asp-Val-Ala-Arg-Leu-Ala-Gly-Val-Ser-Val-Ala-Thr-Val-. Comparison of this sequence with that deduced from the DNA sequence of the galR gene showed that the formyl methionine residue preceding alanine at position 1 is cleaved off. The repressor is present in solution as a dimer of a 37-kDa subunit. The protein binds to gal DNA containing wild type and not mutant operator sequences. As predicted, this sequence-specific binding is inhibited by the presence of D-galactose or D-fucose, both of which are in vivo inducers of the gal operon. Gal repressor inhibits the expresison of gal operon by binding to two spatially separated operators which flank, but do not overlap, the gal promoter segment. Experiments to study the mechanism of repressor action are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  A functional assay in Escherichia coli to detect non-assisted interaction between galactose repressor dimers.

Authors:  N Perez; M Rehault; M Amouyal
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  GalR mutants defective in repressosome formation.

Authors:  M Geanacopoulos; G Vasmatzis; D E Lewis; S Roy; B Lee; S Adhya
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

3.  Structure and stability of the ankyrin domain of the Drosophila Notch receptor.

Authors:  Mark E Zweifel; Daniel J Leahy; Frederick M Hughson; Doug Barrick
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

4.  Operator-bound GalR dimers close DNA loops by direct interaction: tetramerization and inducer binding.

Authors:  Szabolcs Semsey; Mark Geanacopoulos; Dale E A Lewis; Sankar Adhya
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

5.  Structural characterization and corepressor binding of the Escherichia coli purine repressor.

Authors:  K Y Choi; H Zalkin
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

6.  Galactose repressor mediated intersegmental chromosomal connections in Escherichia coli.

Authors:  Zhong Qian; Emilios K Dimitriadis; Rotem Edgar; Prahathees Eswaramoorthy; Sankar Adhya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

7.  Further inducibility of a constitutive system: ultrainduction of the gal operon.

Authors:  J P Tokeson; S Garges; S Adhya
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

8.  DNA sequences in gal operon override transcription elongation blocks.

Authors:  Dale E A Lewis; Natalia Komissarova; Phuoc Le; Mikhail Kashlev; Sankar Adhya
Journal:  J Mol Biol       Date:  2008-07-27       Impact factor: 5.469

9.  Repressor induced site-specific binding of HU for transcriptional regulation.

Authors:  T Aki; S Adhya
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

10.  Homolog comparisons further reconcile in vitro and in vivo correlations of protein activities by revealing over-looked physiological factors.

Authors:  Sudheer Tungtur; Kristen M Schwingen; Joshua J Riepe; Chamitha J Weeramange; Liskin Swint-Kruse
Journal:  Protein Sci       Date:  2019-08-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.